Effects of anti-drug antibody on clinical efficacy and adverse reactions of immunotherapy for non-small cell lung cancer

Autor: ZHAO Xianlan, LI Jixi, YANG Qiao, LI Shixun, YU Yongxin, LI Feng, LI Mengxia, SUN Jianguo

Publikováno v: Di-san junyi daxue xuebao, Vol 43, Iss 17, Pp 1673-1678 (2021)

Objective To explore the effects of anti-drug antibody (ADA) on clinical efficacy and adverse reactions in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). Methods A total of 26 patients with stage �

Externí odkaz: https://doaj.org/article/4104b26225c547e9b0e84d92da07da8f

Human umbilical cord mesenchymal stem cells inhibited the aseptic joint loosening caused by wear particles in mice

Autor: Yue Ding, Li Shixun, Wu Chuangran

Publikováno v: Bone Reports, Vol 14, Iss , Pp 100945- (2021)

Externí odkaz: https://doaj.org/article/117b6bb7e8444db7a5747ed063b3597f

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis

Autor: Lin, Sipeng, Wen, Zhenkang, Li, Shixun, Chen, Zhong, Li, Changchuan, Ouyang, Zhuji, Lin, Chuangxin, Kuang, Manyuan, Xue, Chunyu, Ding, Yue

Publikováno v: In Acta Biomaterialia 1 April 2022 142:345-360

Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non‐small cell lung cancer.

Autor: Hu, Yue¹ (AUTHOR), Li, Shixun¹ (AUTHOR), Xiao, He¹ (AUTHOR), Xiong, Yanli¹ (AUTHOR), Lu, Xianfeng¹ (AUTHOR), Yang, Xiao¹ (AUTHOR), Luo, Wei¹ (AUTHOR), Luo, Jiamin¹ (AUTHOR), Zhang, Shiheng¹ (AUTHOR), Cheng, Yi¹ (AUTHOR), Zhang, Lei¹ (AUTHOR), Dai, Xiaoyan¹ (AUTHOR), Yang, Yuxin¹ (AUTHOR), Wang, Dong¹ (AUTHOR), Li, Mengxia¹ (AUTHOR) mengxia.li@outlook.com

Publikováno v: Cancer Medicine. Jun2023, Vol. 12 Issue 11, p12234-12252. 19p.